OCD: Clinical Trials

2 trials for OCD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1
Phase 21Completed 1

Follow OCD: new trials by email Literature Review of OCD trials Research Report on OCD

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open-Label Psilocybin Study in Transdiagnostic Population
Psilocybin - Transdiagnostic, Depression - Major Depressive Disorder
Phase 1RecruitingYale University502024-10-172026-03-11
Effects of Sertraline on Brain Connectivity in Adolescents With OCD
Sertraline, No Intervention - OCD
Phase 1 / Phase 2CompletedUniversity of Minnesota412013-08-012021-01-05

Narrower conditions

Anxiety Disorders (1)  ·  Behavior, Addictive (1)  ·  Depression (1)  ·  Stress Disorders, Post-Traumatic (1)  ·  Substance-Related Disorders (1)

Broader conditions

Behavior (1)  ·  Behavioral Symptoms (1)  ·  Chemically-Induced Disorders (1)  ·  Compulsive Behavior (1)  ·  Impulsive Behavior (1)  ·  Mental Disorders (1)  ·  Stress Disorders, Traumatic (1)  ·  Trauma and Stressor Related Disorders (1)

Interventions

Psilocybin (1)  ·  Sertraline (1)

Sponsors

University of Minnesota (1)  ·  Yale University (1)

Countries

United States (2)

Top investigators

Benjamin Kelmendi, MD (1)  ·  Gabrielle Agin-Liebes, PhD (1)  ·  Gail A Bernstein, MD (1)

Results publications

PMID 26674413, PMID 30768407

NIH funding

R21MH101395 (1)